Bolton Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.33K Sell
5
-10
-67% -$2.78K ﹤0.01% 2142
2026
Q2
$4.38K Sell
15
-40
-73% -$7.66K ﹤0.01% 1975
2026
Q1
$9.14K Sell
55
-10
-15% -$1.64K ﹤0.01% 1639
2025
Q4
$10.4K Sell
65
-55
-46% -$7.55K ﹤0.01% 1590
2025
Q3
$11.2K Sell
120
-10
-8% -$707 ﹤0.01% 1519
2025
Q2
$7.4K Buy
130
+50
+63% +$2.65K ﹤0.01% 1554
2025
Q1
$4.88K Buy
+80
New +$6.82K ﹤0.01% 1591

Other funds holding LABU

Bolton Securities's LABU Position: Q3 2026 in Review

Bolton Securities reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 67% in Q3 2026, selling an estimated $2.78K and leaving 5 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Bolton Securities first reported a position in LABU in Q1 2025 and has held it in 7 quarters since. The position peaked at $11.2K in Q3 2025. 38 funds tracked by Wall St. Rank hold LABU as of Q3 2026.

  • Bolton Securities held 5 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.33K as of Q3 2026.
  • Bolton Securities sold 10 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2026, an estimated $2.78K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Bolton Securities's portfolio in Q3 2026, its #2142 holding.
  • Bolton Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2025 and has held it in 7 quarters since.
  • Bolton Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $11.2K in Q3 2025.
  • 38 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.